Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Greg Mattingly"'
Autor:
Greg Mattingly
Emily Dickinson (1830-1886) wrote in 19th century American English and referenced long-vanished cultural contexts. A'private poet,'she created her own vocabulary, and many of her poems have quite specific local and personal connections. Twenty-first
Publikováno v:
The Primary Care Companion For CNS Disorders. 25
Autor:
Henry C. Foehl, Greg Mattingly, Robert J. Kupper, Ann C. Childress, Scott H. Kollins, Jeffrey H. Newcorn, Akwete L. Adjei
Publikováno v:
Journal of Child and Adolescent Psychopharmacology
Objectives: To assess the efficacy and safety of a methylphenidate hydrochloride extended-release capsule (MPH-MLR) formulation in treating attention-deficit/hyperactivity disorder (ADHD) in preschool children. Methods: Children aged 4 to
Modelling resilience in adolescence and adversity: a novel framework to inform research and practice
Publikováno v:
Translational Psychiatry, Vol 9, Iss 1, Pp 1-16 (2019)
Translational Psychiatry
Translational Psychiatry
Recent conceptualisations of resilience have advanced the notion that it is a dynamic and multifaceted construct. However, its adaptive components, especially those forged by adversity, have not been fully realised, and its neurobiological and psycho
Publikováno v:
Journal of Child and Adolescent Psychopharmacology
Objectives: In a previous pivotal study of children and adolescents (aged 6–17 years) with attention-deficit/hyperactivity disorder (ADHD), dose-optimized SHP465 mixed amphetamine salts (MAS) extended-release (12.5–25 mg once daily) was superior
Publikováno v:
Journal of Clinical Psychopharmacology
Supplemental digital content is available in the text.
Purpose/Background PRC-063 is a once-daily, extended-release oral formulation of methylphenidate hydrochloride developed to provide early and prolonged symptom improvement in patients with a
Purpose/Background PRC-063 is a once-daily, extended-release oral formulation of methylphenidate hydrochloride developed to provide early and prolonged symptom improvement in patients with a
Publikováno v:
The Australian and New Zealand journal of psychiatry. 54(7)
Autor:
Andrei Pikalov, Debra Phillips, Michael Tocco, Jane Xu, Antony Loebel, Greg Mattingly, Peter Haddad
Publikováno v:
BMC Psychiatry
BMC Psychiatry, Vol 20, Iss 1, Pp 1-13 (2020)
BMC Psychiatry, Vol 20, Iss 1, Pp 1-13 (2020)
Background Patients with a diagnosis of schizophrenia are at an increased risk for developing metabolic syndrome, which is associated with greater cardiovascular morbidity and mortality. Treatment with some commonly used antipsychotic medications may
Publikováno v:
CNS spectrums. 26(3)
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that manifests in childhood and can persist into adolescence and adulthood. Impairments associated with ADHD can impact quality of life, social interactions, and increas
Autor:
Ann C. Childress, Robert J. Kupper, Earl Nordbrock, Greg Mattingly, Akwete L. Adjei, Margaret D. Weiss
Publikováno v:
Journal of Child and Adolescent Psychopharmacology
Objective: To evaluate the relationship between symptom and functional improvement and remission in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) enrolled in an 11-week open-label dose-optimization phase of an methylph